MYRIAD GENETICS, INC. Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
MYRIAD GENETICS, INC. (MYGN) had Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount of $0 as of 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions · last filed 2026-07-31
- 2026-06-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $0.00.
- 2026-03-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $0.00.
- 2025-09-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $0.00.
- 2025-06-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $0.00.
| Period end | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount |
|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-07-31 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-06 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-04 |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-06 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-07 |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-08 |
| 2024-06-30 | $100.00K 10-Q · filed 2024-08-07 |
| 2024-03-31 | $300.00K 10-Q · filed 2024-05-08 |
| 2023-09-30 | $600.00K 10-Q · filed 2023-11-07 |
| 2023-06-30 | $800.00K 10-Q · filed 2023-08-04 |
| 2023-03-31 | $900.00K 10-Q · filed 2023-05-04 |
| 2022-09-30 | $1.40M 10-Q · filed 2022-11-02 |
| 2022-06-30 | $1.70M 10-Q · filed 2022-08-05 |
| 2022-03-31 | $2.00M 10-Q · filed 2022-05-06 |
| 2021-09-30 | $2.60M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $3.40M 10-Q · filed 2021-08-04 |
| 2021-03-31 | $4.00M 10-Q · filed 2021-05-05 |
| 2020-12-31 | $4.60M 10-KT · filed 2021-03-16 |
| 2020-09-30 | $5.20M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $0.00 10-K · filed 2020-08-13 |
| 2020-03-31 | $0.00 10-Q · filed 2020-05-06 |
| 2019-12-31 | $0.00 10-Q · filed 2020-02-07 |
| 2019-09-30 | $0.00 10-Q · filed 2019-11-06 |
| 2019-06-30 | $0.00 10-K · filed 2019-08-13 |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-08 |
| 2018-12-31 | $0.00 10-Q · filed 2019-02-06 |
| 2018-09-30 | $0.00 10-Q · filed 2018-11-07 |
| 2018-06-30 | $0.00 10-K · filed 2018-08-24 |
| 2018-03-31 | $0.00 10-Q · filed 2018-05-09 |
| 2017-12-31 | $0.00 10-Q · filed 2018-02-07 |
| 2017-09-30 | $0.00 10-Q · filed 2017-11-08 |
| 2017-06-30 | $1.00M 10-K · filed 2017-08-09 |
| 2017-03-31 | $2.20M 10-Q · filed 2017-05-03 |
| 2016-12-31 | $3.30M 10-Q · filed 2017-02-08 |
| 2016-09-30 | $4.50M 10-Q · filed 2016-11-02 |
| 2016-06-30 | $6.50M 10-K · filed 2016-08-10 |
| 2016-03-31 | $8.60M 10-Q · filed 2016-05-04 |
| 2015-12-31 | $10.80M 10-Q · filed 2016-02-03 |
| 2015-09-30 | $13.00M 10-Q · filed 2015-11-04 |
| 2015-06-30 | $15.70M 10-K · filed 2015-08-12 |
| 2015-03-31 | $24.40M 10-Q · filed 2015-05-06 |
| 2014-12-31 | $28.70M 10-Q · filed 2015-02-04 |
| 2014-09-30 | $36.00M 10-Q · filed 2014-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |